Internal Medicine, Infectious Disease · Baltimore, MD
NPI
1043264492
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
10 Hopkins Plz, Kaiser Permanente City Plaza Medical Center
Baltimore, MD, 21201
Phone (443) 263-7300
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$3.4M
569 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Mettassebia Kanno prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 104 prescriptions and refills. In total Mettassebia Kanno wrote 569 Medicare prescriptions that cost $3.4M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-20.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 104 | 256 | 37 | $930K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 84 | 237 | 26 | $854K |
| Juluca Dolutegravir/Rilpivirine | 63 | 134 | 15 | $474K |
| Tivicay Dolutegravir Sodium | 37 | 99 | 12 | $243K |
| Prezcobix Darunavir/Cobicistat | 34 | 90 | 12 | $226K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 32 | 79 | Under 11 | $261K |
| Arexvy Rsvpref3 Antigen/As01e/Pf | 22 | 22 | 22 | $3,234 |
| Descovy Emtricitabine/Tenofov Alafenam | 21 | 55 | Under 11 | $103K |
| Cephalexin Generic | 18 | 45 | Under 11 | $673 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 16 | 28 | Under 11 | $101K |
| Atovaquone Generic | 14 | 14 | Under 11 | $5,593 |
| Doxycycline Monohydrate Generic | 14 | 40 | Under 11 | $871 |
| Rifampin Generic | 13 | 39 | Under 11 | $2,303 |
Brand drugs: 457 claims; generic drugs: 112 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Mettassebia Kanno were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.